(Q79820772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dave S. Hoon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Kaneda Y

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Hiramatsu SH

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Huang S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tran AN

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Giuliano AE

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

23 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

451-459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

Human tumor antigens for cancer vaccine development

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Telomerase catalytic subunit homologs from fission yeast and human

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Inhibition of telomerase limits the growth of human cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Chemokines: agents for the immunotherapy of cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Chemokines and cell migration in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Tumour escape from immune surveillance through dendritic cell inactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701035

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17318199%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference